Ronald A. Andrews's Insider Trades & SAST Disclosures
Ronald A. Andrews's most recent trade in Precipio Inc was a trade of 1,785 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ronald A. Andrews.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 5.60 per share. | 15 Apr 2025 | 1,785 | 14,552 (0%) | 0% | 5.6 | 9,996 | Common Stock |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 6.10 per share. | 15 Jan 2025 | 1,639 | 12,767 (0%) | 0% | 6.1 | 9,998 | Common Stock |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2025 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 6.62 per share. | 15 Oct 2024 | 1,510 | 11,128 (0%) | 0% | 6.6 | 9,996 | Common Stock |
| Precipio Inc | Andrews Ronald A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 2,000 | 2,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald Andrews A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2024 | 2,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Andrews Ronald A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2024 | 1,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Andrews Ronald A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 1,250 | 1,250 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Andrews A. Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 258 | 258 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Andrews Ronald A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2024 | 258 | 0 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Andrews A. Ronald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2024 | 103 | 103 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald Andrews A. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 31 Aug 2024 | 103 | 0 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 4.63 per share. | 15 Jul 2024 | 2,157 | 9,618 (0%) | 0% | 4.6 | 9,987 | Common Stock |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,000 | 1,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 6.66 per share. | 15 Apr 2024 | 3,153 | 7,461 (0%) | 0% | 6.7 | 20,999 | Common Stock |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Oncocyte Corporation | Ronald A. Andrews | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 16 Aug 2022 | 40,000 | 333,212 (0%) | 0% | 1.0 | 38,400 | Common Stock, no par value |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 500,000 | 500,000 | - | - | Restricted Stock Units | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 375,000 | 375,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 300,000 | 300,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 200,000 | 200,000 | - | - | Option to Purchase Common Stock | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.28 per share. | 15 Mar 2022 | 50,000 | 293,212 (0%) | 0% | 1.3 | 64,150 | Common Stock, no par value |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 106,221 | 0 | - | - | Restricted Stock Units | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2021 | 106,221 | 219,919 (0%) | 0% | 0 | Common Stock, no par value | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 07 May 2021 | 25,873 | 194,046 (0%) | 0% | 0 | Common Stock, no par value | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.79 per share. | 19 Mar 2021 | 11,000 | 113,698 (0%) | 0% | 4.8 | 52,702 | Common Stock, no par value |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 5,171 | 5 | - | - | Employee Stock Option (right to buy) | |
| Precipio Inc | Ronald A. Andrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,069 | 2,069 | - | - | Employee Stock Option (right to buy) | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 500,000 | 500,000 | - | - | Employee Stock Option (right to buy) | |
| Oncocyte Corporation | Ronald A. Andrews | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.35 per share. | 03 Aug 2020 | 40,000 | 102,698 (0%) | 0% | 1.3 | 53,880 | Common Stock, no par value |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges